{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:53:28Z","timestamp":1778903608146,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Agile Therapeutics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijpharm.2012.12.014","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T03:49:02Z","timestamp":1355975342000},"page":"9-18","source":"Crossref","is-referenced-by-count":26,"title":["Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies"],"prefix":"10.1016","volume":"441","author":[{"given":"Vishal","family":"Sachdeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agis","family":"Kydonieus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.12.014_bib0005","series-title":"Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies","author":"Banga","year":"2011"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0887-2333(94)00190-6","article-title":"Quantitative structure\u2013activity relationships for skin permeability","volume":"9","author":"Barratt","year":"1995","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/17425240802500870","article-title":"Crystallisation within transdermal rotigotine patch: is there cause for concern?","volume":"5","author":"Chaudhuri","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1081\/DDC-120015355","article-title":"In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes","volume":"28","author":"Chisty","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpb.2005.02.001","article-title":"Poly-methacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen","volume":"60","author":"Cilurzo","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0030","unstructured":"Drug Bank and Database 2012. http:\/\/www.drugbank.ca\/drugs\/DB00304 (accessed 07.11.12)."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0035","series-title":"Residual Drug in Transdermal and Related Drug Delivery Systems","article-title":"Guidance for Industry","author":"FDA","year":"2010"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0040","series-title":"Predicting Drug Solubility in Transdermal Adhesives","author":"Foreman","year":"2002"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0045","series-title":"Transdermal and Topical Drug Delivery Systems","author":"Ghosh","year":"1997"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00095-2","article-title":"Passive enhancement strategies in topical and transdermal drug delivery","volume":"184","author":"Hadgraft","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2010.04.042","article-title":"Inhibition of crystallization in drug-in-adhesive-type transdermal patches","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/713840400","article-title":"Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride","volume":"10","author":"Jain","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(02)00017-0","article-title":"Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix","volume":"236","author":"Kim","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0939-6411(01)00174-6","article-title":"Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol","volume":"52","author":"Kotiyan","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0075","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0010-7824(98)00030-4","article-title":"Developments in contraception: a comprehensive review of desogen (desogestrel and ethinyl estradiol)","volume":"57","author":"Lammers","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0939-6411(03)00158-9","article-title":"Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry X-ray diffraction, and optical microscopy","volume":"57","author":"Latsch","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0085","unstructured":"Lexi-Drugs Online 2012. http:\/\/online.lexi.com.proxy.mercer.edu\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6867. Lexi-drugs online (accessed 07.11.12)."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0090","unstructured":"Lipp, R., Gunther, C., Riedl, J., Tauber, U., 1995. Desogestrel containing transdermal application agent. Canadian patent document no. CA 2183544, Canadian Intellectual Property Office. http:\/\/brevets-patents.ic.gc.ca\/opic-cipo\/cpd\/eng\/patent\/2183544\/summary.html (accessed 07.11.12)."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.2042-7158.1998.tb03357.x","article-title":"Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids","volume":"50","author":"Lipp","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0939-6411(98)00055-1","article-title":"Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems","volume":"47","author":"Lipp","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(96)04647-9","article-title":"Control of drug crystallization in transdermal matrix system","volume":"142","author":"Ma","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.aca.2007.02.028","article-title":"High performance liquid chromatography\/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel","volume":"588","author":"Matejicek","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-100102135","article-title":"Evaluation of adhesive properties of patches based on acrylic matrices","volume":"25","author":"Minghetti","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10837450701212701","article-title":"Formulation study of oxybutynin patches","volume":"12","author":"Minghetti","year":"2007","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","article-title":"Predicting skin permeability","volume":"9","author":"Potts","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2010.11.011","article-title":"Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel","volume":"77","author":"Schulz","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0960-0760(95)00055-5","article-title":"Transdermal application of steroid hormones for contraception","volume":"53","author":"Sitruk-Ware","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12272-010-0301-7","article-title":"Recent advances in transdermal drug delivery","volume":"33","author":"Subedi","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1461-5347(99)00119-4","article-title":"Pressure-sensitive adhesives for transdermal drug delivery systems","volume":"2","author":"Tan","year":"1999","journal-title":"Pharm. Sci. Technolo. Today"},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2004.03.009","article-title":"Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro","volume":"278","author":"Valiveti","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/(SICI)1097-4636(19990315)44:4<397::AID-JBM5>3.0.CO;2-Q","article-title":"Crystallization of beta-estradiol in an acrylic transdermal drug delivery system","volume":"44","author":"Variankaval","year":"1999","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2012.12.014_bib0165","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3109\/03639049109048057","article-title":"Transdermal dual-controlled delivery of testosterone and estradiol: (I) impact of system design","volume":"17","author":"Yu","year":"1991","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312010691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312010691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:51:45Z","timestamp":1540007505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312010691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0378517312010691"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.12.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}